Back to Journals » Cancer Management and Research » Volume 11

Concurrent TP53 mutations predict poor outcomes of EGFR-TKI treatments in Chinese patients with advanced NSCLC

Total article views   HTML views PDF downloads Totals
9,256 Dovepress* 6,926+ 1,068 7,994
PubMed Central* 2,330 554 2,884
Totals 9,256 1,622 10,878
*Since 21 June 2019

View citations on PubMed Central and Google Scholar